Bahranian Arefeh, Koshki Mehdi, Farahmandi Fargol, Eftekharian Kourosh, Hemmati Samaneh, Sattari Mahboobe, Zali Alireza, Panahi Ghodratollah
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Biomark Med. 2025 Feb;19(4):129-137. doi: 10.1080/17520363.2025.2455925. Epub 2025 Jan 27.
PURPOSE: Glioblastoma multiforme (GBM) is an aggressive brain tumor. This meta-analysis investigates the association between HOTAIR expression levels and GBM. METHODS: We searched the literature for studies on HOTAIR expression in GBM patients. A meta-analysis of nine studies assessed standardized mean difference (SMD) and 95% confidence intervals (CIs) using a random-effects model. Subgroup analyses were performed based on sample source, country, and study design. Additionally, we conducted meta-regression and publication bias analyses. RESULTS: The meta-analysis found a significant positive association between elevated HOTAIR expression and GBM (SMD = 8.3, 95% CI 5.8-10.8, = 0.00). Considerable heterogeneity was observed (Q-value: 1174.2, df = 9, I = 99.2%, = 0.00). Subgroup analyses indicated significant associations in tissue samples and studies from the USA and China. Meta-regression revealed that study design and country contributed to the observed heterogeneity, with no significant publication bias detected. CONCLUSION: This analysis confirms the significant link between HOTAIR expression and GBM, highlighting HOTAIR as a potential therapeutic target and biomarker. Further research is necessary to clarify the biological mechanisms involved in this association.
Cochrane Database Syst Rev. 2021-5-4
Int J Mol Sci. 2022-8-9
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2022-6-29
Cochrane Database Syst Rev. 2022-4-4
Cochrane Database Syst Rev. 2023-6-14
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2016-3-12
Cell Mol Neurobiol. 2024-2-16
Funct Integr Genomics. 2023-7-31
Biomed Pharmacother. 2022-10
Neurooncol Adv. 2022-5-26
Neuro Oncol. 2021-8-2